Bioavailability of flavonoids

European Journal of Clinical Nutrition

Volumn 51, Issue SUPPL. 1, 1997, Pages

  Hollman, P C H ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Absorption; Antioxidants; Dietary flavonoids; Metabolism

Indexed keywords

CATECHIN; FLAVANONE; FLAVONE; FLAVONOID; FLAVONOL; ISOFLAVONE;

CONFERENCE PAPER; DIET; DRUG BIOAVAILABILITY; HUMAN; NONHUMAN; NUTRITION; ORAL DRUG ADMINISTRATION; RAT; VITAMIN INTAKE; VITAMIN METABOLISM;

ANIMALS; BIOLOGICAL AVAILABILITY; FLAVONOIDS; FOOD; HUMANS; INTESTINAL ABSORPTION;

EID: 0031036740     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (37)

1. Adlercreutz H et al (1991). Urinary excretion of lignons and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am J Clin Nutr. 54: 1093-1100.
2. Adlercreutz H, Markkanen H, Watanabe S (1993). Plasma concentrations of phyto-oestrogens in Japanese men. Lancet. 342: 1209-1210.
3. Balant L, Burki B, Wermeille M, Golden G (1979). Comparison of some pharmacokinetic parameters of (+)-cyanidanol-3 obtained with specific and non-specific analytical methods. Arzneimittel Forsch. 29: 1758-1762.
4. Booth AN, Jones FT, De Eds F (1958a). Metabolic and glucosuria studies on naringin and phlorhizin. J Biol Chem. 233: 280-288.
5. Booth AN, Jones FT, De Eds F (1958b). Metabolic fate of hesperidin, eriodictyol, homeriodictyol, and diosmin. J Biol Chem. 230: 661-668.
6. Bors W, Heller W, Michel C, Saran M (1990). Flavonoids as antioxidants: Determination of radical-scavenging efficiencies. Method Enzymol. 186: 343-355.
7. Cova D et al (1992). Pharmacokinetics and metabolism of oral diosmin in healthy volunteers. Int J Clin Pharmacol Ther Toxicol. 30: 29-33.
8. Goldbohm RA et al (1995). Flavonoid intake and risk of cancer: a prospective cohort study. Am J Epidemiol. 141(Suppl): S61.
9. Griffiths L (1982). Mammalian metabolism of flavonoids. In: Harborne J, Mabry T (eds). The Flavonoids: Advances in Research. Chapman and Hall: London, pp 681-718.
10. Griffiths L, Smith GE (1972). Metabolism of apigenin and related compounds in the rat. Metabolite formation in vivo by the intestinal microflora in vitro. Biochem J. 128: 901-911.
11. Gugler R, Leschik M, Dengler HJ (1975). Disposition of quercetin in man after single oral and intravenous doses. Eur J Clin Pharmacol. 9: 229-234.
12. Hackett AM (1983). The metabolism and excretion of (+)-14C-cyanidanol-3 in man following oral administration, Xenobiotica. 13: 279-286.
13. Hackett AM (1986). The metabolism of flavonoid compounds in mammals. In: Cody V, Middleton E, Harborne J (eds). Plant Flavonoids in Biology and Medicine: Biochemical, Pharmacological, Structure-Activity Relationships. Alan R. Liss, Inc: New York, pp 177-194.
14. Hackett AM, Griffiths LA, Wermeille M (1985). The quantitative disposition of 3-O-methyl-[U-14C]catechin in man following oral administration. Xenobiotica. 15: 907-914.
15. Halliwell B (1994). Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?. Lancet. 344: 721-724.
16. Hermann K (1990). Occurrence and contents of flavonoids in fruit-I. Catechins and Proanthocyanidins (Vorkommen und Gehalte der Flavonoide in Obst-I. Catechine und Proanthocyanidine). Erwerbsobstbau. 32: 4-7.
17. Hertog MGL, Hollman PCH, Katan MB (1992). Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. J Agric Food Chem. 40: 2379-2383.
18. Hertog MGL, Hollman PCH, van de Putte B (1993a). Content of potentially anticarcinogenic flavonoids of tea infusions, wines, and fruit juices. J Agric Food Chem. 41: 1242-1246.
19. Hertog MGL, Hollman PCH, Katan MB, Kromhout D (1993b). Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands. Nutr Cancer. 20: 21-29.
20. Hertog MGL et al (1993c). Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet. 342: 1007-1011.
21. Hertog MGL et al (1994). Dietary flavonoids and cancer risk in the Zutphen Elderly Study. Nutr Cancer. 22: 175-184.
22. Hertog MGL et al (1995). Flavanoid intake and long-term risk of coronary heart disease and cancer in the Seven Countries Study. Arch Intern Med. 155: 381-386.
23. Hollman PCH et al (1995). Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am J Clin Nutr. 62: 1276-1282.
24. Huang M-T, Ferraro T (1992). Phenolic compounds in food and cancer prevention. In: Huang M-T, Ho C, Lee CY (eds). Phenolic Compounds in Food and Their Effects on Health II. Antioxidants & Cancer Prevention. American Chemical Society: Washington DC, pp 8-34.
25. Keli SO, Hertog MGL, Feskens EJM, Kromhout D (1996). Flavonoids, antioxidant vitamins and risk of stroke. The Zutphen Study. Arch Intern Med. 156: 637-642.
26. Kühnau J (1976). The Flavonoids. A class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet. 24. 117-191.
27. Lee M-J et al (1995). Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol Biomark Prev. 4: 393-399.
28. Mazza G (1995). Anthocyanins in grapes and grape products. CRC Crit Rev Food Sci Nutr. 35: 341-371.
29. Middleton E, Kandaswami C (1994). The impact of plant flavonoids on mammalian biology: implications for immunity, inflammation and cancer. In: Harborne JB (ed). The Flavonoids: Advances in Research Since 1986. Chapman & Hall: London, pp 619-652.
30. Nieder M (1991). Pharmakokinetik der Ginkgo-Flavonole im Plasma Münch Med Wochenschr. 133(suppl 1): S61-S62.
31. Rusznyk S, Szent-Györgyi A (1936). Vitamin P: Flavonols as vitamins. Nature. 138: 27.
32. Salah N et al (1995). Polyphenolic flavonols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch Biochem Biophys. 322: 339-346.
33. Singleton VL (1981). Flavonoids. In: Childester CO, Mrak EM, Stewart GF (eds). Advances in Food Research. Academic Press: New York, pp 149-242.
34. Swain T (1980). Flavonoids as chemotaxonomic markers in plants. In: Czygan FC (ed). Pigments in Plants. Gustav Fischer Verlag: Stuttgart, pp 224-236.
35. Ueno I, Nakano N, Hirono I (1982). Metabolic fate of [14C]quercetin in the ACI rat. Jpn J Exp Med. 53: 41-50.
36. de Whalley C et al (1990). Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. Biochem Pharmacol 39: 1743-1750.
37. Xu X et al (1994). Daidzin is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr. 124: 825-832.